Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $25,570 - $28,845
-100 Reduced 12.5%
700 $202 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $174,920 - $217,167
800 New
800 $215 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Greenland Capital Management LP Portfolio

Follow Greenland Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenland Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Greenland Capital Management LP with notifications on news.